The content on this website is intended solely for veterinarians and other animal health professionals.
By using this website, you confirm that the above applies to you.
The Board of Directors in Intervacc has resolved on a fully covered rights issue of approximately SEK 104 million
NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONGKONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER...Veterinary Medicines Directorate (VMD) extends the shelf life for Strangvac, a vaccine against equine strangles, to 33 months
Stockholm, May 8th, 2023 – The Veterinary Medicines Directorate (VMD) the authority responsible for veterinary medicines in the UK has, after reviewing stability data, approved the extension of the shelf life for Strangvac®, to 33 months from previously 24...CORRECTION: NOTICE OF ANNUAL GENERAL MEETING IN INTERVACC AB (PUBL)
The correction refers to the proposal Item no 8, the number of Board members, elected by the AGM, shall be seven. The shareholders of Intervacc AB (publ), reg. no. 556238-1748 (the “Company”), are hereby invited to the Annual General Meeting (“AGM”) to be held on...NOTICE OF ANNUAL GENERAL MEETING IN INTERVACC AB (PUBL)
A correction to this press release has been published, please use this link for all documents prior to the 2023 AGM. The shareholders of Intervacc AB (publ), reg. no. 556238-1748 (the “Company”), are hereby invited to the Annual General Meeting (“AGM”) to be held on...Report from Extraordinary General Meeting in Intervacc
Intervacc AB (publ) has held its Extraordinary General Meeting (”EGM”) on Friday 5 May 2023, at which a resolution on authorisation for the board of directors to resolve on rights issue of shares was made. The EGM authorised the board of directors to, in the period...Nyhetstjänster
